Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. - sprookjes - yvandenbroek - TriplyDB

Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.

Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.

http://www.wikidata.org/entity/Q47415758

about

Adjuvant percutaneous radiofrequency ablation of feeding artery of hepatocellular carcinoma before treatment.Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma.Long-term outcomes of hepatectomy vs percutaneous ablation for treatment of hepatocellular carcinoma < or =4 cm Effect of treatment support on preventing local recurrence of hepatocellular carcinoma directly adjacent to the diaphragm.Effect of pre- and post-treatment α-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study.Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies Prospective evaluation of microscopic extension using whole-mount preparation in patients with hepatocellular carcinoma: Definition of clinical target volume for radiotherapy.Heat stress induced cell death mechanisms in hepatocytes and hepatocellular carcinoma: in vitro and in vivo study Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy.Construction and clinical significance of a predictive system for prognosis of hepatocellular carcinoma.Use of transient elastography to predict de novo recurrence after radiofrequency ablation for hepatocellular carcinoma.Laparoscopic treatment of liver tumours using a two-needle probe bipolar radiofrequency ablation device.Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: a randomized trial.Phase I study of heat-deployed liposomal doxorubicin during radiofrequency ablation for hepatic malignancies.Heat Stress-Induced PI3K/mTORC2-Dependent AKT Signaling Is a Central Mediator of Hepatocellular Carcinoma Survival to Thermal Ablation Induced Heat Stress Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors.Radiofrequency ablation for hepatocellular carcinoma: use of low vs maximal radiofrequency power Ultrasonogram of hepatocellular carcinoma is associated with outcome after radiofrequency ablation.Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment.Laparoscopic resection vs laparoscopic radiofrequency ablation for the treatment of small hepatocellular carcinomas: A single-center analysis.CT and MRI of hepatocellular carcinoma: an update.Clinical outcomes of radiofrequency ablation and surgical resection for small hepatocellular carcinoma: a meta-analysis.Risk factors for early intrahepatic distant recurrence after radiofrequency ablation for hepatocellular carcinoma in Egyptian patients.Radiofrequency ablation: post-ablation assessment using CT perfusion with pharmacological modulation in a rat subcutaneous tumor model.Proinflammatory cytokines increase hepatocellular carcinoma cells thermotolerance: evidence of how local inflammation may negatively impact radiofrequency ablation local control rates.Modeling doxorubicin transport to improve intratumoral drug delivery to RF ablated tumors.Model simulation and experimental validation of intratumoral chemotherapy using multiple polymer implants.Complete remission of diffuse hepatocellular carcinoma in a young adult after GSP-TACE: a case report.Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma.Heat stress induced, ligand-independent MET and EGFR signalling in hepatocellular carcinoma."Edgeboost": A Novel Technique to Extend the Ablation Zone Lateral to a Two-Probe Bipolar Radiofrequency Device.Utility of computed tomography fusion imaging for the evaluation of the ablative margin of radiofrequency ablation for hepatocellular carcinoma and the correlation to local tumor progression.Recurrence rates and factors for recurrence after radiofrequency ablation combined with transarterial chemoembolization for hepatocellular carcinoma: a retrospective cohort study.Curative-intent stereotactic body radiation therapy for residual breast cancer liver metastasis after systemic chemotherapy.Signal intensity of small hepatocellular carcinoma on apparent diffusion coefficient mapping and outcome after radiofrequency ablation.Risk factors for survival and local recurrence after particle radiotherapy for single small hepatocellular carcinoma.Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.Salvage hepatectomy for local recurrent hepatocellular carcinoma after ablation therapy.Ablação por radiofrequência de tumores hepáticos primários e metastáticos: experiência em 113 casos

P2860

Q33460537-6EC73240-196A-440D-89C7-4DE3A6150628 Q33658239-6D67AFB0-D114-430F-AEAD-0019E25BCC4F Q33788290-E9D75BE4-3779-434B-8F27-7E76DD2675B1 Q33857944-9624A14B-FCEF-4864-9F9B-569A10796460 Q33937557-8A90A576-0140-4442-8224-29BEA888EABA Q34003699-3B085985-AB7A-4F03-96CC-34834763F6B2 Q34117026-B16B7CE3-BB23-4DC7-858E-A5B7C76ED1F1 Q34722346-E3BAF01C-345F-4734-8B19-F9D7E94FF808 Q35010404-9419A387-F30E-4822-86DA-2372498DC111 Q35010945-CFC0C6EA-C88A-40F0-81E4-5A3FFDBA387D Q35067549-7125D761-9B83-4EB9-81AD-EF0777EA4644 Q35244242-F9D81CAA-7E0D-492F-94D2-A37DD72E37CC Q35273624-01465C46-C3AC-4AD2-AC01-E47AFB71C90D Q35690829-A15E9E0D-088C-412C-8F32-1C2287A55E39 Q36128222-4672B4D0-68F6-4E65-8A15-609110004E33 Q36205766-15604DF7-1118-40E1-8C1B-7CFD118D998E Q36326256-5757BDD9-285C-4DAB-BDBA-9927E004A89F Q36561581-7444CA7F-EFE0-4437-8FAD-B83D6B6383F3 Q36656608-163359CD-02B5-413F-A14D-D0D188C4FB29 Q37625219-154371F0-8CA4-4BB4-825A-5E791B965A05 Q37732278-A15C6BCB-024C-4A7B-A0A5-A9375C1EC160 Q37946476-D82557D8-6258-4BB0-9D59-B27375409E78 Q39263681-CA341AFF-02CF-4F7A-BDC6-3A2AEAB3C0BE Q39886168-6B6433E1-347F-4F68-873B-0E0D08BB169C Q40014857-DC968D8B-D3C6-4E22-97B1-4C6D76064BA3 Q40075182-4C1CA4C9-E846-4703-A945-8F58135EEE08 Q41479927-F4EC7A88-88FB-4527-986D-867812EC37B3 Q43144725-B9B132FA-3309-42F9-930F-95045266ABD2 Q45340189-7C8824A3-8BF4-4E63-8CE0-DB07EFFC4917 Q47910739-CE0B67EA-7551-4D04-A82F-C4B8A08F412D Q48161122-7EEB0DD7-E310-4E93-A972-95E6B0D869DF Q49014010-F53D20C1-BE1C-4F2A-866D-708D05B168D3 Q51023061-03E588F1-0F74-4E1C-AF76-627E0B52A7D6 Q51442292-42DF77FF-EEB8-4455-ABC0-A5861E1CD6FD Q51752811-BB88B05A-D491-472E-907B-9537EC859641 Q53249221-20E24632-CCFB-47CA-8006-DC4F3D30B096 Q53257181-798475DE-8D39-4028-84D8-442761258EE0 Q53671436-24A47ECB-57EB-46F0-B3A4-59E9695A6568 Q58861158-57F3171F-7BD8-4078-815C-44B1BA1176BB

P2860

Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.

http://www.wikidata.org/entity/Q47415758

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Locoregional recurrences are f ...... for hepatocellular carcinoma.

@en

Locoregional recurrences are f ...... for hepatocellular carcinoma.

@nl

type

label

Locoregional recurrences are f ...... for hepatocellular carcinoma.

@en

Locoregional recurrences are f ...... for hepatocellular carcinoma.

@nl

prefLabel

Locoregional recurrences are f ...... for hepatocellular carcinoma.

@en

Locoregional recurrences are f ...... for hepatocellular carcinoma.

@nl

P1433

Q47415758-90B0C7DC-8584-4BCF-8769-FF3B0698BCC1

P1476

Q47415758-EDA93327-B2E3-471F-BF18-5743FE16420A

P2093

Q47415758-19700F91-267E-424E-8FA8-85D306E87FFE

Q47415758-2ED119BD-16D0-44ED-BA36-B473C179E56C

Q47415758-3BEB971B-175E-4C3D-A2A0-7842FB7E4F91

Q47415758-690C0F59-7CFC-43A8-A68D-2A844AF39E2A

Q47415758-8185AB9C-B03E-4AFC-90B1-F137A262BE75

Q47415758-C4CEA166-B9D1-45DD-B412-72608D3EFF79

Q47415758-DB1D36A4-38FA-4CA9-95CA-3B8A79A9FA2B

Q47415758-E8DEE655-220C-49E9-B470-67582C5D10B3

Q47415758-F3B07268-7105-4EC1-8340-8B0DFDC22575

Q47415758-FCB9D514-50F6-4D39-A8DD-7F8D463FDF08

P304

Q47415758-EA14FB8A-6DCD-4B68-8DDA-20F455D54995

P31

Q47415758-18B431A3-B8AD-4A6A-9516-ACB2EF6124B6

P356

Q47415758-57F7ABC5-DC76-4AFA-AB0C-B8C83DC5A253

P433

Q47415758-428D38DF-E3CE-4AB0-950C-E0A58481520B

P478

Q47415758-3FD8E3D1-06E4-42FC-A3FC-E2A6BEC56D4B

P577

Q47415758-2AC22268-C4A2-45DF-9562-F3D614C86523

P698

Q47415758-033F03AE-3797-4FFB-8604-0058AAE168A7

P356

S1072-7515(03)00750-6

P1433

Journal of the American College of Surgeons

P1476

Locoregional recurrences are f ...... for hepatocellular carcinoma.

@en

P2093

Adrian Fisher

http://www.w3.org/2001/XMLSchema#string

Alison Barone

http://www.w3.org/2001/XMLSchema#string

Andrew Dela Torre

http://www.w3.org/2001/XMLSchema#string

Baburao Koneru

http://www.w3.org/2001/XMLSchema#string

Daniel Contractor

http://www.w3.org/2001/XMLSchema#string

Dorian Wilson

http://www.w3.org/2001/XMLSchema#string

Kyunghee C Cho

http://www.w3.org/2001/XMLSchema#string

Lawrence E Harrison

http://www.w3.org/2001/XMLSchema#string

Maria Korogodsky

http://www.w3.org/2001/XMLSchema#string

Phil Baramipour

http://www.w3.org/2001/XMLSchema#string

P304

759-764

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1072-7515(03)00750-6

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

197

http://www.w3.org/2001/XMLSchema#string

P577

2003-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14585410

http://www.w3.org/2001/XMLSchema#string